Main > > >MASTOCYTOSIS. (PRECANCEROUS). *

---

Treat.: Imatinib Mesylate Tab. Brand
(*) Company : Novartis
Patent : Expired
TradeMark: Gleevec
Web-Site : www.us.gleevec.com
UpDate: 2018. 10.14.




Treat.: Imatinib Mesylate Tab. Generic.
USA Launch Date: 2017. 09.29.
(*) Company : Mylan NV.
UpDate: 2018. 10.14.




Treat.: Imatinib Mesylate Tab. Generic.
USA Launch Date: 2016. 02.01.
(*) Company: Sun Pharma.
UpDate: 2018. 10.14.

Treat.: Midostaurin Capsules.
EU Approval Date : 2017. 09.20.
USA Approval Date: 2017. 04.28.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 10.14.


>MASTOCYTOSIS. (PRECANCEROUS). *'s products
This section has no products